{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:21:58Z","timestamp":1773393718028,"version":"3.50.1"},"reference-count":50,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,1,15]]},"DOI":"10.2169\/internalmedicine.1817-23","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T22:11:31Z","timestamp":1684275091000},"page":"145-152","source":"Crossref","is-referenced-by-count":4,"title":["Zinc Supplementation and an Improved Quality of Life in Patients with Autoimmune Hepatitis"],"prefix":"10.2169","volume":"63","author":[{"given":"Kei","family":"Moriya","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keigo","family":"Saeki","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihisa","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Takaya","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Kaji","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideto","family":"Kawaratani","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Namisaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takemi","family":"Akahane","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Yoshiji","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Takahashi A, Ohira H, Abe K, et al. Increasing incidence of acute autoimmune hepatitis: a nationwide survey in Japan. Sci Rep 10: 14250, 2020.","DOI":"10.1038\/s41598-020-71296-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lamba M, Ngu JH, Stedman CAM. Trends in incidence of autoimmune liver diseases and increasing incidence of autoimmune hepatitis. Clin Gastroenterol Hepatol 19: 573-579.e1, 2021.","DOI":"10.1016\/j.cgh.2020.05.061"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tanaka A. Emerging novel treatments for autoimmune liver diseases. Hepatol Res 49: 489-499, 2019.","DOI":"10.1111\/hepr.13347"},{"key":"4","unstructured":"4. The Intractable Hepato-Biliary Disease Study Group in Japan. Clinical practice Guidelines: autoimmune hepatitis. ver 3 [Internet]. [updated 2021 Jan; cited 2016 Mar 20]. Available from: http:\/\/www.hepatobiliary.jp\/uploads\/files\/AIH%E3%82%AC%E3%82%A4%E3%83%89%E3%83%A9%E3%82%A4%E3%83%B3ver3%202020.1.27%281%29.pdf (in Japanese)"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology 72: 671-722, 2020.","DOI":"10.1002\/hep.31065"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Schmidt T, Schmidt C, Strahl A, et al. A system to determine risk of osteoporosis in patients with autoimmune hepatitis. Clin Gastroenterol Hepatol 18: 226-233.e3, 2020.","DOI":"10.1016\/j.cgh.2019.05.043"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chew LC, Maceda-Galang LM, Tan YK, Chakraborty B, Thumboo J. <i>Pneumocystis jirovecii<\/i> pneumonia in patients with autoimmune disease on high-dose glucocorticoid. J Clin Rheumatol 21: 72-75, 2015.","DOI":"10.1097\/RHU.0000000000000215"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Patten SB, Neutel CI. Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf 22: 111-122, 2000.","DOI":"10.2165\/00002018-200022020-00004"},{"key":"9","unstructured":"9. Brody DJ, Pratt LA, Hughes JP. Prevalence of depression among adults aged 20 and over: United States, 2013-2016. NCHS Data Brief 303: 1-8, 2018."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Olsson G, von Knorring AL. Beck&apos;s Depression Inventory as a screening instrument for adolescent depression in Sweden: gender differences. Acta Psychiatr Scand 95: 277-282, 1997.","DOI":"10.1111\/j.1600-0447.1997.tb09632.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Schramm C, Wahl I, Weiler-Normann C, et al. Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis. J Hepatol 60: 618-624, 2014.","DOI":"10.1016\/j.jhep.2013.10.035"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wong LL, Fisher HF, Stocken DD, et al. The impact of autoimmune hepatitis and its treatment on health utility. Hepatology 68: 1487-1497, 2018.","DOI":"10.1002\/hep.30031"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 51: 1037-1044, 1998.","DOI":"10.1016\/S0895-4356(98)00095-X"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 45: 295-300, 1999.","DOI":"10.1136\/gut.45.2.295"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Janik MK, Wunsch E, Raszeja-Wyszomirska J, et al. Autoimmune hepatitis exerts a profound, negative effect on health-related quality of life: a prospective, single-centre study. Liver Int 39: 215-221, 2019.","DOI":"10.1111\/liv.13960"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Trevizoli IC, Pinedo CS, Teles VO, Seixas RBPM, de Carvalho E. Autoimmune hepatitis in children and adolescents: effect on quality of life. J Pediatr Gastroenterol Nutr 66: 861-865, 2018.","DOI":"10.1097\/MPG.0000000000001930"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Takahashi A, Moriya K, Ohira H, et al. Health-related quality of life in patients with autoimmune hepatitis: a questionnaire survey. PLOS ONE 13: e0204772, 2018.","DOI":"10.1371\/journal.pone.0204772"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Takahashi A, Abe M, Yasunaka T, et al. Quality of life among patients with autoimmune hepatitis in remission: a comparative study. Med (Baltim) 99: e22764, 2020.","DOI":"10.1097\/MD.0000000000022764"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Nishikawa H, Enomoto H, Yoh K, et al. Serum zinc concentration and quality of life in chronic liver diseases. Med (Baltim) 99: e18632, 2020.","DOI":"10.1097\/MD.0000000000018632"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Pereira TC, Saron ML, Carvalho WA, Vilela MM, Hoehr NF, Hessel G. Research on zinc blood levels and nutritional status in adolescents with autoimmune hepatitis. Arq Gastroenterol 48: 62-65, 2011.","DOI":"10.1590\/S0004-28032011000100013"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Salari S, Khomand P, Arasteh M, Yousefzamani B, Hassanzadeh K. Zinc sulphate: a reasonable choice for depression management in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial. Pharmacol Rep 67: 606-609, 2015.","DOI":"10.1016\/j.pharep.2015.01.002"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Solati Z, Jazayeri S, Tehrani-Doost M, Mahmoodianfard S, Gohari MR. Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized, placebo-controlled trial. Nutr Neurosci 18: 162-168, 2015.","DOI":"10.1179\/1476830513Y.0000000105"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ranjbar E, Shams J, Sabetkasaei M, et al. Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression. Nutr Neurosci 17: 65-71, 2014.","DOI":"10.1179\/1476830513Y.0000000066"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kanda Y. Investigation of the freely available easy-to-use software &apos;EZR&apos; for medical statistics. Bone Marrow Transplant 48: 452-458, 2013.","DOI":"10.1038\/bmt.2012.244"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ridola L, Nardelli S, Gioia S, Riggio O. Quality of life in patients with minimal hepatic encephalopathy. World J Gastroenterol 24: 5446-5453, 2018.","DOI":"10.3748\/wjg.v24.i48.5446"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Dyson JK, De Martin E, Dalekos GN, et al.; IAIHG Consortium. Review article: unanswered clinical and research questions in autoimmune hepatitis-conclusions of the International Autoimmune Hepatitis Group Research Workshop. Aliment Pharmacol Ther 49: 528-536, 2019.","DOI":"10.1111\/apt.15111"},{"key":"27","unstructured":"27. Gandhi S, Khubchandani S, Iyer R. Quality of life and hepatocellular carcinoma. J Gastrointest Oncol 5: 296-317, 2014."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Haraldstad K, Wahl A, Anden\u00e6s R, et al. A systematic review of quality of life research in medicine and health sciences. Qual Life Res 28: 2641-2650, 2019.","DOI":"10.1007\/s11136-019-02214-9"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Werner M, Prytz H, Ohlsson B, et al. Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol 43: 1232-1240, 2008.","DOI":"10.1080\/00365520802130183"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. van den Brand FF, van der Veen KS, Lissenberg-Witte BI, et al. Adverse events related to low dose corticosteroids in autoimmune hepatitis. Aliment Pharmacol Ther 50: 1120-1126, 2019.","DOI":"10.1111\/apt.15528"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Fritz E, Hammer J. Gastrointestinal symptoms in patients with liver cirrhosis are linked to impaired quality of life and psychological distress. Eur J Gastroenterol Hepatol 21: 460-465, 2009.","DOI":"10.1097\/MEG.0b013e328318ed19"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kim SH, Oh EG, Lee WH. Symptom experience, psychological distress, and quality of life in Korean patients with liver cirrhosis: a cross-sectional survey. Int J Nurs Stud 43: 1047-1056, 2006.","DOI":"10.1016\/j.ijnurstu.2005.11.012"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Siwek M, Dudek D, Schlegel-Zawadzka M, et al. Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. J Affect Disord 126: 447-452, 2010.","DOI":"10.1016\/j.jad.2010.04.024"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Maes M, Vandoolaeghe E, Neels H, et al. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune\/inflammatory response in that illness. Biol Psychiatry 42: 349-358, 1997.","DOI":"10.1016\/S0006-3223(96)00365-4"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Katayama K, Hosui A, Sakai Y, et al. Effects of zinc acetate on serum zinc concentrations in chronic liver diseases: a multicenter, double-blind, randomized, placebo-controlled trial and a dose adjustment trial. Biol Trace Elem Res 195: 71-81, 2020.","DOI":"10.1007\/s12011-019-01851-y"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Mousa N, Abdel-Razik A, Zaher A, et al. The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial. Ther Adv Gastroenterol 9: 684-691, 2016.","DOI":"10.1177\/1756283X16645049"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. M\u0142yniec K, Davies CL, Budziszewska B, et al. Time course of zinc deprivation-induced alterations of mice behavior in the forced swim test. Pharmacol Rep 64: 567-575, 2012.","DOI":"10.1016\/S1734-1140(12)70852-6"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Sigwalt AR, Budde H, Helmich I, et al. Molecular aspects involved in swimming exercise training reducing anhedonia in a rat model of depression. Neuroscience 192: 661-674, 2011.","DOI":"10.1016\/j.neuroscience.2011.05.075"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Siod\u0142ak D, Nowak G, Mlyniec K. Interaction between zinc, the GPR39 zinc receptor and the serotonergic system in depression. Brain Res Bull 170: 146-154, 2021.","DOI":"10.1016\/j.brainresbull.2021.02.003"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Tsuji T, Naito Y, Takagi T, et al. Role of metallothionein in murine experimental colitis. Int J Mol Med 31: 1037-1046, 2013.","DOI":"10.3892\/ijmm.2013.1294"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Ghosh R, Kumar PK, Mitra P, Purohit P, Nebhinani N, Sharma P. Circulating T helper 17 and IFN-gamma positive Th17 cells in Major depressive disorder. Behav Brain Res 394: 112811, 2020.","DOI":"10.1016\/j.bbr.2020.112811"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Zhao L, Tang Y, You Z, et al. Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. Plos One 6: e18909, 2011.","DOI":"10.1371\/journal.pone.0018909"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Ueda K, Ueyama T, Oka M, Ito T, Tsuruo Y, Ichinose M. Polaprezinc (zinc L-carnosine) is a potent inducer of anti-oxidative stress enzyme, heme oxygenase (HO)-1 - a new mechanism of gastric mucosal protection. J Pharmacol Sci 110: 285-294, 2009.","DOI":"10.1254\/jphs.09056FP"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Ooi TC, Chan KM, Sharif R. Zinc L-carnosine suppresses inflammatory responses in lipopolysaccharide-induced RAW 264.7 murine macrophages cell line via activation of Nrf2\/HO-1 signaling pathway. Immunopharmacol Immunotoxicol 39: 259-267, 2017.","DOI":"10.1080\/08923973.2017.1344987"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Mangano K, Cavalli E, Mammana S, et al. Involvement of the Nrf2\/HO-1\/CO axis and therapeutic intervention with the CO-releasing molecule CORM-A1, in a murine model of autoimmune hepatitis. J Cell Physiol 233: 4156-4165, 2018.","DOI":"10.1002\/jcp.26223"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. El-Agamy DS, Shaaban AA, Almaramhy HH, Elkablawy S, Elkablawy MA. Pristimerin as a novel hepatoprotective agent against experimental autoimmune hepatitis. Front Pharmacol 9: 292, 2018.","DOI":"10.3389\/fphar.2018.00292"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Patidar KR, Thacker LR, Wade JB, et al. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization. Am J Gastroenterol 109: 1757-1763, 2014.","DOI":"10.1038\/ajg.2014.264"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Kappus MR, Bajaj JS. Covert hepatic encephalopathy: not as minimal as you might think. Clin Gastroenterol Hepatol 10: 1208-1219, 2012.","DOI":"10.1016\/j.cgh.2012.05.026"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Goode HF, Robertson DA, Kelleher J, Walker BE. Effect of fasting, self-selected and isocaloric glucose and fat meals and intravenous feeding on plasma zinc concentrations. Ann Clin Biochem 28: 442-445, 1991.","DOI":"10.1177\/000456329102800503"},{"key":"50","unstructured":"50. Roohani N, Hurrell R, Kelishadi R, Schulin R. Zinc and its importance for human health: an integrative review. J Res Med Sci 18: 144-157, 2013."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/2\/63_1817-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T03:21:43Z","timestamp":1705720903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/2\/63_1817-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,15]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1817-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,15]]},"article-number":"1817-23"}}